63rd Annual Meeting | Fall 2021
As you know from our previous emails and updates to the Aspen Lung Conference website (https://medschool.cuanschutz.edu/aspen), we recently made the decision to reschedule the 63rd Aspen Lung Conference to the Fall of 2021. We are now pleased to announce that we will be hosting the 63rd Conference at the Gant Conference Center in Aspen, Colorado between September 20th-23rd, 2021 with an in-person/hybrid format.
We have also moved the Abstract submission deadline to June 1st 2021. We will be sending regular updates about the Conference by email and through posts on the website.
Please continue to check the website for up to date information regarding reservations, registration and other Conference information.
ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity
The 63rd Annual Thomas L. Petty Aspen Lung Conference will convene at the Gant Conference Center in Aspen, Colorado. The theme of the conference will be “ARDS in the 21st Century: New Insights into Clinical and Mechanistic Heterogeneity.”
The Acute Respiratory Distress Syndrome (ARDS) represents a common syndrome arising from numerous, heterogeneous, and often-independent disease processes. Accordingly, a single ARDS study drug, if uniformly applied to all patients regardless of underlying disease pathophysiology, would likely fail to consistently improve patient outcomes. For clinical studies to overcome this obstacle, a new appreciation of ARDS mechanistic and phenotypic heterogeneity is required, enabling future precision medicine approaches to the recognition and treatment of lung injury.
The 2021 Thomas L. Petty Aspen Lung Conference will integrate basic, translational, and clinical approaches to address the impact of ARDS heterogeneity, with a focus on (1) understanding the presence and therapeutic significance of ARDS mechanistic and phenotypic subtypes, (2) exploring multi-cellular and multi-systemic mechanisms responsible for this heterogeneity, and (3) determining how to best account for disease heterogeneity during clinical trial design and outcome assessment. Heterogeneity within COVID-19 ARDS, as well as between COVID-19 and non-COVID-19 ARDS, will also be discussed.
This conference will provide an international forum bringing together leading basic, translational, and clinical ARDS researchers while welcoming trainees in pulmonology and critical care medicine, with the goal of identifying shared interests that will lead to more productive research and more effective personalized therapies. Finally, the varied scientific themes and therapeutic strategies emerging during the conference will be reconciled in a concluding Conference Summary presented by Dr. Thomas Martin (University of Washington).
Local/Regional/National/International Physicians/Clinicians (adult and pediatric)/Research Physician-Scientists in Pulmonary Sciences, Critical Care and Sleep Medicine/Research Scientists (PhD) in lung injury/Primary Care Physicians/General Medicine Physicians/Public
We invite you and your colleagues to submit abstracts for consideration for a podium presentation and/or a poster at the conference. We are particularly interested in attracting translational basic or clinical research abstracts related to the selected thematic topics.
We will offer three Thomas L. Petty Fellow Travel Awards in the amount of $1,000 each to three female and under-represented minority fellows whose abstracts have been accepted for podium presentations.
For more information, contact: Eric Schmidt, M.D., c/o Jeanne Cleary, Thomas L. Petty Aspen Lung Conference, PO Box 1231, Parker, CO 80134 Phone: (303) 358-2797. E-Mail: Jeanne.Cleary@cuanschutz.edu.
Americans with Disabilities Act Statement: Please indicate if you have any need for auxiliary aids or special assistance services.